Skip to main content

Table 2 Relationship between CDX2 expression and survival in patients after potentially curative liver metastasectomy

From: Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Survival (days) CDX2 expression Univariate HR (95% CI) P value
High Low
Median DFS 420 245 1.53 (1.03–2.26) 0.032
Median OS 3145 1024 2.45 (1.55–3.86) < 0.001
  1. HR Hazard ratio, OS Overall survival, DFS Disease-free survival